Research programme: anti-FLT-1 monoclonal antibody - BioWa

Drug Profile

Research programme: anti-FLT-1 monoclonal antibody - BioWa

Alternative Names: BIW 8556; FLT-1 monoclonal antibody; KM 2550

Latest Information Update: 06 Dec 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator BioWa
  • Class Monoclonal antibodies
  • Mechanism of Action Vascular endothelial growth factor receptor-1 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Solid tumours

Most Recent Events

  • 29 May 2007 Preclinical development is ongoing
  • 17 May 2005 This compound is still in active development - (BioSquare-2005)
  • 03 Mar 2004 Anti-FLT-1 monoclonal antibody is available for licensing in Europe, North America and South America (http://www.biowa.com)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top